Urination difficulty with prostatic hypertrophy

摘要

The present invention provides a therapeutic agent for dysphagia, which does not affect blood pressure, which contains an. Alpha. 1L adrenergic receptor subtype high selective blocking agent as an active ingredient. The. Alpha. 1L adrenergic receptor subtype as a highly selective blocking agent, for example, (-) - (R) - 1 - (3-hydroxypropyl) - 5 - [2 - [2 - [2 - (2,2 - (2-trifluoroethoxy) phenoxy] ethyl] amino] propyl), India line-7-carboxamide, the drug Physiologically acceptable salts or their solvates or (-) - (R) - 1 - (3-hydroxypropyl) - 5 - [2 - [2 - [2 - (2,2 - (2-trifluoroethoxy) phenoxy] ethyl] amino] propyl] - doldole-7-carboxamide Salt or their solvate is effective as an effective ingredient, and the therapeutic agent for dyspnea is generated according to the usual method.